Q32 Bio Inc. Share Price
QTTBQ32 Bio Inc. Stock Performance
Open $5.07 | Prev. Close $4.90 | Circuit Range N/A |
Day Range $4.89 - $5.17 | Year Range $1.34 - $8.01 | Volume 3,123 |
Average Traded $5.02 |
Q32 Bio Inc. Share Price Chart
About Q32 Bio Inc.
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.
Q32 Bio Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
08-Apr-26 | $6.00 | $5.44 | -8.57% |
07-Apr-26 | $5.70 | $5.95 | +5.12% |
06-Apr-26 | $6.05 | $5.66 | -11.77% |
02-Apr-26 | $5.92 | $6.42 | +5.68% |
01-Apr-26 | $6.61 | $6.07 | -4.56% |
31-Mar-26 | $6.26 | $6.36 | +7.43% |
30-Mar-26 | $7.13 | $5.92 | -18.34% |